Jeffrey M Liebmann1, Keith Barton2, Robert N Weinreb3, David A Eichenbaum4, Preeya K Gupta5, Cathleen M McCabe6, Jeremy D Wolfe7, Iqbal Ahmed8,9, Arsham Sheybani10, E Randy Craven11. 1. Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY. 2. Glaucoma Service, Moorfields Eye Hospital, UCL Institute of Ophthalmology, London, UK. 3. Shiley Eye Institute, Hamilton Glaucoma Center, University of California, San Diego, CA. 4. Morsani College of Medicine, University of South Florida, Tampa, FL. 5. Duke University Eye Center, Duke University, Durham, NC. 6. The Eye Associates, Sarasota, FL. 7. William Beaumont School of Medicine, Oakland University, Rochester Hills, MI. 8. University of Utah, Salt Lake City, UT. 9. Kensington Eye Institute, University of Toronto, Toronto, Ontario, Canada. 10. Washington University School of Medicine, St Louis, MO. 11. Wilmer Eye Institute, Johns Hopkins Medical School, Baltimore, MD.
Abstract
PURPOSE: To review evidence and provide guidelines on intracameral (ICM) injection techniques and monitoring. MATERIALS AND METHODS: A review of published literature on ICM injection and intravitreal injections formed the basis for roundtable deliberations by an expert panel of ophthalmologists. RESULTS: ICM injection as a way to deliver medications is growing in popularity. However, there is limited published literature and no standard approach to best practices for ICM injections, particularly when not accompanying another surgical procedure. Fortunately, there is long clinical experience with ICM manipulation and a large body of evidence surrounding intravitreal injections that has provided important guidance. The expert panel formulates several concrete guidelines and many suggested techniques to help physicians safely and effectively employ ICM injections. CONCLUSIONS: This committee addressed the many considerations surrounding ICM injection of drugs or implants and agree that it is a safe and effective surgical procedure when performed with appropriate training and according to established safe practices.
PURPOSE: To review evidence and provide guidelines on intracameral (ICM) injection techniques and monitoring. MATERIALS AND METHODS: A review of published literature on ICM injection and intravitreal injections formed the basis for roundtable deliberations by an expert panel of ophthalmologists. RESULTS: ICM injection as a way to deliver medications is growing in popularity. However, there is limited published literature and no standard approach to best practices for ICM injections, particularly when not accompanying another surgical procedure. Fortunately, there is long clinical experience with ICM manipulation and a large body of evidence surrounding intravitreal injections that has provided important guidance. The expert panel formulates several concrete guidelines and many suggested techniques to help physicians safely and effectively employ ICM injections. CONCLUSIONS: This committee addressed the many considerations surrounding ICM injection of drugs or implants and agree that it is a safe and effective surgical procedure when performed with appropriate training and according to established safe practices.
Authors: Bo Tian; Evan Bilsbury; Sean Doherty; Sean Teebagy; Emma Wood; Wenqi Su; Guangping Gao; Haijiang Lin Journal: Pharmaceutics Date: 2022-09-13 Impact factor: 6.525